XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis

The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review

(2017) Munetaka Takekuma et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Extracellular matrix endocytosis in controlling matrix turnover and beyond: emerging roles in cancer

(2016) Elena Rainero   BIOCHEMICAL SOCIETY TRANSACTIONS

EMT in cervical cancer: Its role in tumour progression and response to therapy

(2015) Rehana Qureshi et al.   CANCER LETTERS

Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives

(2014) Xiao-mei Zhou et al.   TUMOR BIOLOGY

The Development of a Novel Molecular Assay Examining the Role of Aminopeptidase P Polymorphisms in Acute Hypotensive Transfusion Reactions

(2013) Yiang Hui et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Epithelial-to-mesenchymal transition and stem cells in endometrial cancer

(2013) Cristina Mirantes et al.   HUMAN PATHOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition

(2011) Chun-Yu Lin et al.   CANCER SCIENCE

A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema

(2011) Amy L. Cilia La Corte et al.   HUMAN MUTATION

Differential alteration of two aminopeptidases N associated with resistance to Bacillus thuringiensis toxin Cry1Ac in cabbage looper

(2011) K. Tiewsiri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Aminopeptidase A inhibitors as centrally acting antihypertensive agents

(2008) Laurence Bodineau et al.   HEART FAILURE REVIEWS